In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine project championed by two scientists who were recently tapped to serve in senior roles within the National Institutes of Health, according to emails reviewed by The Wall Street Journal. The unusually large sum comes as the nation’s health agencies are cutting budgets, shrinking staff and terminating hundreds of active research grants.